Patient Reported Outcome Measures After Treatment of Skin Cancers on the Face

Last updated: November 20, 2023
Sponsor: University Hospital, Basel, Switzerland
Overall Status: Active - Not Recruiting

Phase

N/A

Condition

Skin Cancer

Melanoma

Malignant Melanoma

Treatment

data collection (photos of the patients' tumors)

data collection by questionnaires

Clinical Study ID

NCT04485442
2018-00301; ch20Schaefer2
  • Ages > 18
  • All Genders

Study Summary

This study is to evaluate the psychological well-being in patients diagnosed with skin cancer (melanoma and Squamous Cell Carcinoma (SCC) in the face) at the time of diagnosis and after treatment. Patients diagnosed with primary melanoma and/or SCC and/or infiltrative basal cell carcinoma on the face subjected to surgical treatment (excision or Mohs Surgery) will be included. All patients will receive questionnaires.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • individuals diagnosed with melanoma, SCC and/or infiltrative basal cell carcinoma onthe face for surgical treatment and planned for excision or Mohs surgery
  • patients who are able to give informed consent

Exclusion

Exclusion Criteria:

  • Electrodesication and curettage of the tumour

Study Design

Total Participants: 100
Treatment Group(s): 2
Primary Treatment: data collection (photos of the patients' tumors)
Phase:
Study Start date:
November 09, 2020
Estimated Completion Date:
August 31, 2024

Connect with a study center

  • Department of Plastic, Reconstructive and Aesthetic Surgery and Department of Dermatology , University Hospital Basel

    Basel, 4031
    Switzerland

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.